Stroke Trial, Recruiting NCT06830785 Sponsor: Shu-Mei Wang Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06830785
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with either an ischaemic (blocked blood vessel) or haemorrhagic (bleeding) stroke, and for whom this was their first stroke
  • People whose stroke affected only one side of the body
  • People whose stroke occurred at least six months ago, meaning they are in the longer-term recovery stage
  • People whose affected arm and hand have a movement ability level rated between stages four and six on the Brunnstrom scale, meaning the affected arm is able to perform the upper-limb movement training used in this study (confirm with trial site)
  • People whose affected arm has a Modified Ashworth Scale score of 2 or below, meaning there is no significant muscle stiffness or spasticity in that arm
  • People who score 24 or higher on the Montreal Cognitive Assessment, a standard thinking and memory test, showing they can understand and follow instructions during the study
  • People who, when their eyes are closed and a clap is made near the ear on their affected side, are able to indicate where the sound came from — either by speaking or using gestures — showing they have at least some hearing in that ear and can respond to rhythmic sound cues

Who may not be able to join:

  • People who have other neurological conditions or health issues that affect movement in their arms or affect their hearing
  • People who are currently taking part in another research study involving drug treatments or upper-limb movement therapy

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Shu-Mei Wang
Registry
ClinicalTrials.gov
Start date
26 March 2025
Est. completion
31 December 2026

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Nine-Hole Peg Test; Nine-Hole Peg Test; Box and Block Test; Box and Block Test

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov